文献速递生殖医学母胎医学

植入前遗传学检测周期中囊胚活检后活产儿的新生儿结局:对1721名儿童的随访

Neonatal outcomes of live births after blastocyst biopsy in preimplantation genetic testing cycles: a follow-up of 1,721 children.
PubMed 文献 · Fertil Steril · 2019-05-02

该回顾性队列研究在大学附属中心比较囊胚活检联合冻胚移植(PGT组)与体外受精或卵胞浆内单精子注射后冻融囊胚移植(对照组)的活产儿结局。结果显示单胎和双胎中性别比、胎龄、早产、出生体重及低出生体重等均无显著差异;但双胎中PGT组剖宫产率显著高于对照组(调整比值比2.383[1.079, 5.259])。荧光原位杂交-PGT中,不同活检细胞数(≥10组与<10组)的新生儿结局无差异,但B级滋养外胚层评分亚组中≥10组男婴比例显著高于<10组(83.3% vs. 40.9%)。

要点

  • 囊胚活检联合冻胚移植后单胎和双胎的新生儿结局与对照组无显著差异。
  • 双胎中PGT组剖宫产率显著高于对照组(调整比值比2.383[1.079, 5.259])。
  • B级滋养外胚层评分亚组中活检细胞≥10组男婴比例83.3% vs. <10组40.9%。

核心结论

  • 与对照组相比,囊胚活检可能不会增加新生儿结局的额外风险。

研究设计与样本

  • 回顾性队列研究,在大学附属中心进行,随访1721名儿童,比较囊胚活检联合冻胚移植(PGT组)与体外受精或卵胞浆内单精子注射后冻融囊胚移植(对照组)的活产儿。

主要发现

  • 单胎和双胎中,PGT组与对照组的性别比、胎龄、早产、极早产、超早产、出生体重及低出生体重、极低出生体重、巨大儿发生率均无显著差异。
  • 双胎中PGT组剖宫产率显著高于对照组(调整比值比2.383[1.079, 5.259])。
  • 荧光原位杂交-PGT中,B级和C级滋养外胚层评分亚组内,活检细胞≥10组与<10组的胎龄、出生体重及早产、极早产、低出生体重、极低出生体重发生率均无差异。
  • B级滋养外胚层评分亚组中,活检细胞≥10组男婴比例显著高于<10组(83.3% vs. 40.9%)。
  • 活检细胞数与胎龄/出生体重的关联无统计学显著性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate whether blastocyst biopsy in preimplantation genetic testing (PGT) increases the risk of adverse neonatal outcomes. DESIGN: Retrospective cohort study. SETTING: University-affiliated center. PATIENTS: Live births after blastocyst biopsy combined with frozen ET (PGT group) and frozen blastocyst transfer after in vitro fertilization or intracytoplasmic sperm injection (control group). INTERVENTION(S): Blastocyst biopsy. MAIN OUTCOME MEASURE(S): Gestational age (GA), birth weight (BW), and rates of preterm birth (PB), very preterm birth (VPB), extreme preterm birth (EPB), low birth weight (LBW), very low birth weight (VLBW), and macrosomia. RESULT(S): No significant differences were observed in the sex ratio, GA, PB, VPB, EPB, BW, or rates of LBW, VLBW, and macrosomia between the PGT and control groups for either singletons or twins. However, the cesarean section rate of the PGT group was significantly higher than that of the control group for twins (adjusted odds ratio, 2.383 [1.079, 5.259]). Regarding fluorescence in situ hybridization-PGT neonates, neonatal outcomes, including GA, BW, and rates of PB, VPB, LBW, and VLBW, did not differ between the different groups of biopsied cells (≥10 group and <10 group) for either the grade B or grade C trophectoderm score subgroups; however, in the grade B trophectoderm score subgroup, the rate of boy babies in the ≥10 group was significantly higher than that in the <10 group (83.3% vs. 40.9%). The association between the number of biopsied cells and GA/BW was not statistically significant. CONCLUSION(S): Blastocyst biopsy may not add additional risk to neonatal outcomes when compared with a control group.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. He H, Jing S, Lu CF, et al. Neonatal outcomes of live births after blastocyst biopsy in preimplantation genetic testing cycles: a follow-up of 1,721 children. Fertil Steril. 2019. PMID: 31056308. doi:10.1016/j.fertnstert.2019.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。